New combination of drugs effective against aggressive brain tumour


Researchers at IGP have identified a certain group of patients with malignant glioblastoma brain tumours that respond to a therapy targeting the cancer gene MYCN. The research findings are published in the scientific journal Cell Death & Disease.

More information:
News posting on the University web (in Swedish)
Article in Cell Death & Disease
Fredrik Swartling’s research forskning